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Abstract
1. The degree to which the RhoA kinase (ROK) blockers, Y-27632 (1 μM)
and HA-1077 (10 μM), and the PKC blocker, GF-109203X (1 μM),
reduced force produced by carbachol, a muscarinic receptor agonist,
and phenylephrine, an -adrenoceptor agonist, was examined in rabbit
stomach fundus smooth muscle.
2. When examining the effect on cumulative carbachol concentrationresponse curves (CRCs), ROK and PKC blockers shifted the potency
(EC50) to the right but did not reduce the maximum response.
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3. In a single-dose carbachol protocol using moderate (∼EC50) and
maximum carbachol concentrations, Y-27632 and HA-1077 reduced
peak force, but GF-109203X had no effect. By contrast, all three
agents inhibited the carbachol contractions of rabbit bladder (detrusor)
smooth muscle.
4. Compared to carbachol, phenylephrine produced a weaker maximum
response that was not inhibited by phentolamine, atropine nor
capsaicin but was inhibited by Y-27632 , HA-1077 and GF-109203X.
5. In detrusor, classical down-regulation occurred, but in fundus, upregulation of responsiveness occurred. This up-regulation in fundus
may have been a post-receptor event, because a KCl-induced
contraction produced after a carbachol CRC was stronger than one
produced before the carbachol stimulus.
6. In conclusion, these data suggest that ROK plays a critical role in the
regulation of rabbit fundus smooth muscle contraction, which is
distinct from chicken gizzard smooth muscle, where ROK is reported to
exist but to not play a role in muscarinic receptor-induced contraction.
Additional unique findings are that PKC participates in phenylephrinebut not carbachol-induced contraction in fundus, that carbachol does
not activate identical subcellular signalling systems in fundus and
detrusor, and that fundus, unlike detrusor, responds to carbachol
stimulation with post-receptor up-regulation of contraction.

Keywords: Signal transduction, stomach fundus, detrusor, smooth muscle,
Ca2+-sensitization, RhoA kinase inhibitors

Introduction
Several reports published just over a decade ago revealed that
smooth muscle contractile proteins could be ‘sensitized' to Ca2+
(Nishimura et al., 1988; Fujiwara et al., 1989; Kitazawa et al., 1989).
In a review, Karaki (1989) described Ca2+ sensitization as a
mechanism by which receptor agonists produce greater increases in
force for a given increase in [Ca2+]i than a stimulus such as KCl. This
model remains valid, except that recent reports indicate that KCl can
also modulate the degree of Ca2+ sensitivity (Yanagisawa & Okada,
1994; Ratz, 1995; Mita et al., 2002), although to a lesser degree
(Ratz, 1999). The precise mechanisms that cause Ca2+ sensitization
are still being investigated. However, in general terms, Ca2+
sensitization may be due to an alteration in the sensitivity of myosin
light chain (MLC) phosphorylation to Ca2+, principally through
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inhibition of MLC phosphatase by RhoA kinase (ROK) and protein
kinase C (PKC), and to thin filament regulation (Hori & Karaki, 1998;
Somlyo & Somlyo, 2000).
Y-27632 and HA-1077 have recently proven invaluable in
identification of the relative role that Ca2+ sensitization plays in
regulation of contraction of intact smooth muscles of different organ
systems. In permeabilized guinea-pig ileum, the ROK inhibitors, Y27632 and HA-1077, inhibit GTPγS-induced Ca2+ sensitized contraction
with IC50 values of, respectively, 1.7 μM and 2.7 μM (Sward et al.,
2000). In arterial tissue, Y-27632 is reported to inhibit tonic
contraction with an IC50 value of 0.7 μM (Uehata et al., 1997). These
values are similar to Ki values reported for inhibition of ROK activity by
these agents (Uehata et al., 1997; Davies et al., 2000; Sward et al.,
2000), and a recent thorough study documenting the specificity of 28
commercially available kinase inhibitors indicates that Y-27632 and
HA-1077 are highly selective for inhibition of ROK when used at
appropriate concentrations (Davies et al., 2000).
To date, Y-27632 or HA-1077 is reported to inhibit vascular
(Uehata et al., 1997), respiratory (Chiba et al., 1999), ileal (Sward et
al., 2000), bladder (Jezior et al., 2001) and myometrial (Kupittayanant
et al., 2001) smooth muscle contractions. However, the degree to
which these agents inhibit, and thus, the extent by which ROK
participates in contractions appears to differ in different smooth
muscle types. For example, 10 μM Y-27632 only modestly reduces
spontaneous human myometrial contractions (Kupittayanant et al.,
2001), but abolishes tonic α-adrenoceptor-induced contraction of
rabbit aorta (Uehata et al., 1997). Muscarinic receptor stimulation
induces a biphasic contraction of ileum, bladder and chicken gizzard
consisting of a rapid, peak contraction (phasic component) followed by
a tonic component that is weaker than the peak response. ROK
blockade by Y-27632 or HA-1077 abolishes the tonic component but
leaves the phasic component nearly intact in ileum (Sward et al.,
2000), while in bladder, both components are greatly diminished
(Jezior et al., 2001). Interestingly, despite the finding that GTPγS
induces ROK activation and Ca2+ sensitization in chicken gizzard
smooth muscle, muscarinic receptor stimulation does not cause ROKdependent Ca2+ sensitization in this muscle type (Anabuki et al.,
2000). However, Y-27632 does reduce gastric antrum motility in
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conscious rats (Tomomasa et al., 2000). The present study was
designed to determine whether the selective ROK inhibitors, Y-27632
and HA-1077, inhibit contractions produced in isolated rabbit stomach
fundus smooth muscle. For a comparison, the ability of GF-109203X,
an inhibitor of conventional and novel PKC isotypes (Gailly et al.,
1997), to inhibit fundus contraction was examined, and the effects of
each agent on muscarinic receptor-induced contraction of rabbit
bladder wall (detrusor) smooth muscle was tested.

Methods
Tissue preparation
Female New Zealand White rabbits (∼2 kg) were killed by CO2
asphyxiation or intravenous injection of a 191 mg kg−1 chloral
hydrate/40 mg kg−1 pentobarbitone solution, as approved by the
Marquette University Institutional Animal Care and Use committee.
Stomach and bladder were removed, cleaned of adipose, loose
connective tissue and mucosa of the stomach and transitional
epithelium of the detrusor and stored in physiological salt solution
(PSS) ((in mM) NaCl 140, KCl 4.7, Na2HPO4 1.2, MgSO4 1.2, CaCl2 1.6,
glucose 5.6, EDTA 0.02, 3-(N-morpholino)propanesulfonic acid 2.0, pH
7.4 at 37°C) at 4°C for up to 72 h until use.
Immediately before use each tissue was cut into longitudinal
strips ∼8 mm and ∼10 mm long (fundus and detrusor, respectively)
and ∼2 mm wide. Strips were clamped on each end, with the clamps
secured between hooks on a stationary metal rod and a metal rod
hanging on an isometric force transducer (Harvard Apparatus,
Holliston, MA, U.S.A.), in PSS bubbled with 95% O2/5% CO2 in waterjacketed muscle chambers (Radnoti Glass Technology, Monrovia, CA,
U.S.A.) at 37°C. The length of each strip was varied by repositioning of
the stationary metal rod.

Mechanical measurements
Strips were stretched to a passive tension of 1.75–2.25 g and
1.00–1.50 g (fundus and detrusor, respectively) and were allowed to
equilibrate for 1 h. To contract tissues, PSS was then replaced with K+-
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PSS, which had the same composition as PSS except that 109 mM KCl
and 70 mM NaCl were substituted for 140 mM NaCl. After active force
reached a maximum (3–7 min, chambers were flushed three times
with PSS, muscle length was increased 0.5–2.0 mm depending on
active force produced, and strips were given a 20 min incubation
period before K+-PSS was added again. If active force was not
significantly different between the two contractions, muscle length was
not changed. If force was significantly different, muscle length was
adjusted and K+-PSS was added a third time. The muscle length
producing maximum force was designated Lo. At the end of the
experiment, wet weight was recorded for each strip, and the force
produced per cross-sectional area was calculated as F/A (N/m2)=(F (g)
*9.807×10−3) / ((wet weight (mg)/Lo (mm)) * 9.52×10−7). On
average, when contracted with K+-PSS, fundus strips produced
∼2×105 N/m2 while detrusor strips produced ∼8×104 N/m2.

Cumulative concentration-response curve (CRC)
protocol
For CRC studies, concentrations of agonist producing zero active
force (10−9 M) to those producing maximum active force (10−5 M to
10−3 M) were added cumulatively to the muscle chamber. When force
reached maximum after a dose was added (3–7 min), the next dose
was added. After the curve was completed, chambers were flushed
with PSS and incubated for 20 min, and an antagonist was added to
chambers containing experimental muscle strips. Control tissues were
not exposed to an antagonist, but were otherwise treated identically to
experimental tissues. All antagonists were allowed at least 20 min
incubation, except capsaicin, which was allowed 1 h incubation. After
the incubation period, a second CRC was repeated on experimental
and control strips.

Single dose (concentration) protocol
Concentrations of agonist producing maximum and halfmaximum active force were computed from CRCs. These
concentrations were then used for single-dose studies (i.e., tissues
were exposed to a single concentration of agonist rather than to
multiple cumulative concentrations). Maximum concentrations were:
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3×10−6 M carbachol and 10−4 M phenylephrine, and half-maximum
concentrations were: 1.2×10−7 M carbachol and 5.2×10−6 M
phenylephrine for fundus and 3×10−6 M (Max) and 1.1×10−7 M (halfmax) carbachol for the detrusor. After force reached a maximum (2–
3.5 min), chambers were flushed and incubated in PSS for 30 min, and
the activation was repeated a second time. After force reached a
maximum, chambers were flushed, incubated in PSS for 10 min, and
an antagonist was added to the chamber (for experimental strips).
Muscle strips were incubated for an additional 20 min, and a third
activation with contractile agonist was performed. Control strips were
not exposed to an antagonist, but were otherwise treated identically.

Analysis of data
Voltage signals from force transducers were digitized by
PowerLab 400 or 4SP hardware (ADInstruments, Castle Hill, Australia)
visualized on a computer screen by the program Chart v3.6 or 4.0
(ADInstruments) as force (g) at 10 Hz and stored by software
command to a hard disk for later analyses. Analyses were performed
with the spreadsheet program Excel 2000 (Microsoft, Redmond, WA,
U.S.A.). Active force from an agonist was normalized to maximum
force from K+-PSS (F/Fo) or to the first contraction produced by a
contractile agonist (e.g., FTrial2/FTrial1). Best-fit CRCs characterized by
the four parameters of a sigmoidal curve (maximum, minimum, slope,
and the concentration producing half-maximum active force (EC50))
were determined with the program GraphPad (GraphPad Software,
Inc., San Diego, CA, U.S.A.). Figures were constructed using
SigmaPlot v5.0 (SPSS, Chicago, IL, U.S.A.).

Statistics
Statistical comparisons were carried out with the program
Statistica (StatSoft, Tulsa, OK, U.S.A.). For CRC studies, maximum
force (F/Fo) and log EC50 (M) were compared. For single dose studies,
forces (F/Fo) of the second (Trial 2) and third (Trial 3) contractions
were compared. A one-way repeated measures ANOVA with a between
grouping factor was used to test the null hypothesis that any
difference of changes between trials in experimental groups to
changes between trials in the control group was due to chance. The
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null hypothesis was rejected at P<0.05. If the null hypothesis was
rejected, planned comparison contrast analyses were performed to
determine which specific experimental groups differed from the control
group. The null hypothesis in these tests was also that differences
were due to chance, and this hypothesis was rejected at P<0.05. A
paired T-test was used to test for significant differences between
maximum force produced from CRCs and maximum force produced
from a single dose activation as well as the difference between force
from the KCl contractions before and after carbachol activations. Data
are expressed as mean±s.e.mean. The value of n is equal to the
number of rabbits from which strips were obtained.

Drugs
Agonists used were carbachol (Acros Organics, NJ, U.S.A.) and
phenylephrine (PE) (Sigma, St. Louis, MO, U.S.A.). Antagonists were
10−7 M atropine (Sigma), 10−6 M capsaicin (ICN Pharmaceuticals,
Costa Mesa, CA, U.S.A.), 10−6 M GF-109203X (GF) or GF-109203X-HCl
(both which gave similar results, Calbiochem, La Jolla, CA, U.S.A.),
10−5 M HA-1077 (HA) (ICN), 10−6 M phentolamine (Sigma), and
3×10−6 M Y-27632 (Y) (Calbiochem). All drugs were reconstituted in
distilled water at the desired dose, except capsaicin which was
reconstituted in 100% ETOH.

Results
Effects of antagonists on carbachol-induced cumulative
concentration-response curves (CRCs) in fundus
Original experimental traces of typical CRCs of tissue strips to
carbachol are presented in Figure 1a,b,d,e). The maximum force
values produced during the first and second carbachol-induced CRCs
were not different, although the average maximum response of the
second response (2.02±0.10 F/Fo) was slightly larger than the first
(1.74±0.09 F/Fo; Figure 1c). Likewise, the potencies (EC50) of
carbachol produced during the first (−6.60±0.09) and second
(−6.49±0.07) CRCs were not different (Figure 1c). Analysis of
variance showed significant differences between the first and second
trial without (control) and with antagonists added. As expected, 10−7 M
British Journal of Pharmacology, Vol. 137, No. 7 (December 2002): pg. 983-992. DOI. This article is © Wiley and
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.

7

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

atropine produced a large rightward shift in the carbachol CRC without
a reduction in the maximum response (Figures 1f and and2a),2a),
indicating that the carbachol-induced contraction in this tissue is due
to activation of muscarinic receptors.

Figure 1 Typical force tracings produced by fundus muscle strips in response
to the cumulative addition of carbachol in the absence (a, b and d) and
presence (e) of 10−7 M atropine. Arrows and numbers indicate when carbachol
(concentration shown in −log units) was added. (a) and (b) are tracings from
one tissue, and (d) and (e) are tracings from another tissue. After a first
carbachol concentration-response curve (CRC) was generated (a and d),
tissues were washed for 30 min to cause relaxation, and either no drug
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(control) or a drug was added for at least 20 min (not shown). A second
carbachol CRC was then generated (b and e). Data from Trial 1 and Trial 2
CRCs were fitted to a sigmoidal curve characterized by the four parameters
shown in the inserts of (c, n=13) and (f, n=4). A similar protocol was used to
examine the effects of GF-109203X, HA-1077 and Y-27632 (see Figure 2.

Figure 2 Carbachol cumulative response curves. Comparisons of maximum
force values (a) and EC50 values (b) produced by Trial 1 and Trial 2 carbachol
CRC in fundus muscle strips (see Figure 1 legend for protocol). Tissues were
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either not treated (control) or treated with an antagonist for at least 20 min
before Trial 2. Data are means+s.e.mean. Control, n=13; 10−7 M atropine,
n=4; 10−6 M GF-109203X (GF), n=7; 10−5 M HA1077 (HA), n=4; 3×10−6 M Y27632 (Y), n=4.

The inhibitor of conventional and novel isoforms of PKC (PKCc,n),
GF-109203X, and the inhibitors of ROK, HA-1077 and Y-27632 had no
effect on the maximum contraction produced by carbachol (Figure 2a).
However, all three agents produced a slight but significant reduction in
the potency of contraction (Figure 2b).

Effects of antagonists on contractions produced by
single doses of carbachol in fundus
The maximum force values from the second and third
contractions (Trial 2 and Trial 3, respectively) were not significantly
different when normalized to the maximum force value produced by
the first contraction (Trial 1; control in Figure 3a). This was found also
to be the case when the PKCn,c inhibitor, GF-109203X, was added to
tissues 20 min before the third stimulation with carbachol (i.e., Trial 3
contraction was not different than Trial 2 contraction; GF in Figure 3a).
However, the ROK inhibitors, HA-1077 and Y-27632, both inhibited
maximum force when added for 20 min before tissues were contracted
with carbachol a third time (HA and Y in Figure 3a). The degree of
inhibition by HA-1077 and Y-27632 was even more pronounced when
tissues were contracted with a lower (EC50) concentration of carbachol
(Figure 3b). However, GF-109203X had no effect on maximum
contraction produced by this lower carbachol concentration (Figure
3b).

British Journal of Pharmacology, Vol. 137, No. 7 (December 2002): pg. 983-992. DOI. This article is © Wiley and
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.

10

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 3 Carbachol single dose response. Comparisons of maximum force
values (a) and half-maximum force values (b) produced by Trial 2 and Trial 3
single-dose carbachol stimulus in fundus muscle strips. Tissues were either
not treated (control) or treated with an antagonist for 20 min before Trial 3.
Data are means+s.e.mean. Control, n=9; 10−6 M GF-109203X (GF), n=4;
10−5 M HA-1077 (HA), n=5; 3×10−6 M Y-27632 (Y), n=4.
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Effects of antagonists on contractions produced by
single doses of carbachol in detrusor
When contracted using the single-dose protocol, detrusor, like
fundus, produced two identical maximum contractions (i.e., the second
and third contractions were not different from each other when
normalized to the first contraction; control in Figure 4). This was true
when using carbachol concentrations that produced maximum (Figure
4a) and EC50 (Figure 4b) responses. Also like fundus, detrusor smooth
muscle was inhibited by both ROK inhibitors (HA-1077 and Y-27632),
although detrusor was inhibited to a greater degree than was fundus.
In detrusor, Y-27632 produced ∼50% inhibition of maximum
carbachol-induced contraction (Figure 4a), while producing only ∼15%
inhibition in fundus (Figure 3a). Likewise, Y-27632 produced over 80%
inhibition of the contraction produced by an EC50 concentration of
carbachol in detrusor (Figure 4b), but produced less than 50%
inhibition in fundus (Figure 3b).

British Journal of Pharmacology, Vol. 137, No. 7 (December 2002): pg. 983-992. DOI. This article is © Wiley and
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.

12

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 4 Comparisons of maximum force values (a) and half-maximum
force values (b) produced by Trial 2 and Trial 3 single-dose carbachol
stimulus in detrusor muscle strips. Tissues were either not treated (control) or
treated with an antagonist for 20 min before Trial 3. Data are
means+s.e.mean. Control, n=7; 10−6 M GF-109203X (GF), n=4; 10−5 M HA1077 (HA), n=6; 3×10−6 M Y-27632 (Y), n=5.
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Unlike fundus, in the detrusor, the PKCc,n inhibitor, GF-109203X,
inhibited contractions produced by both a maximum (Figure 4a) and
EC50 (Figure 4b) concentration of carbachol.

Effects of antagonists on phenylephrine-induced
cumulative concentration-response curves (CRCs) in
fundus
Although muscarinic receptor activation is the primary
autonomic receptor responsible for fundus smooth muscle contraction,
-adrenoceptor activation may also participate (Bulbring & Tomita,
1987). Thus, we examined the effects of inhibitors of ROK and PKCc,n
to determine the relative contribution of these enzymes to contractions
produced by the -adrenoceptor agonist, phenylephrine. Original
experimental traces of a typical contractile response show that
cumulative addition of phenylephrine does cause contraction of fundus
(Figure 5a). However, this tissue was not highly responsive to
phenylephrine (insert, Figure 5c), given that the maximum contraction
was, on average, ∼0.3-fold that produced by KCl, and the potency was
7 μM, a value equal to that in ovarian artery, but over 10 fold less
potent than thoracic aorta (Oriowo et al., 1987). The -adrenoceptor
blocker, phentolamine, produced a marked rightward shift in the
phenylephrine CRC without producing a reduction in the maximum
response (Figure 5a vs b; 5c and phentolamine in Figure 6).
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Figure 5 Typical force tracings produced by fundus muscle strips in response
to the cumulative addition of phenylephrine in the absence (a) and presence
(b) of 10−6 M phentolamine. Arrows and numbers indicate when
phenylephrine (concentration shown in −log units) was added. After a first
phenylephrine concentration-response curve (CRC) was generated (a), tissues
were washed for 30 min to cause relaxation, and either no drug (control) or
phentolamine was added for at least 20 min (not shown). A second
phenylephrine CRC was then generated (b). Data from Trial 1 and Trial 2
CRCs were fitted to a sigmoidal curve characterized by the four parameters
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shown in the insert of (c, n=4). A similar protocol was used to examine the
effects of atropine, capsaicin, GF-109203X, HA-1077 and Y-27632 (see Figure
6).

Figure 6 PE cumulative response curves. Comparisons of maximum force
values (a) and EC50 values (b) produced by Trial 1 and Trial 2 phenylephrine
CRC in fundus muscle strips (see Figure 5 legend for protocol). Tissues were
either not treated (control) or treated with an antagonist for at least 20 min
(60 min for capsaicin) before Trial 2. Data are means+s.e.mean. Control,
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n=15; 10−6 M phentolamine, n=4; 10−7 M atropine, n=4; 10−6 M capsaicin,
n=4; 10−6 M GF-109203X (GF), n=8; 10−5 M HA-1077 (HA), n=7; 3×10−6 M
Y-27632 (Y), n=7.

The muscarinic receptor blocker, atropine, and the vallinoid
receptor agonist and sensory nerve toxin, capsaicin, had no effect on
phenylephrine CRCs in rabbit fundus (Figure 6). These data support
the contention that phenylephrine caused contraction by stimulation of
α-adrenoceptors, and not by indirectly causing release of motor or
sensory nerve neurotransmitters. The PKCc,n blocker, GF-109203X and
the ROK blockers, HA-1077 and Y-27632 reduced the maximum
response (Figure 6a) and produced a small but significant reduction in
the potency (Figure 6b) of phenylephrine contractions.

Effects of antagonists on contractions produced by
single doses of phenylephrine in fundus
As seen with carbachol stimulation in both fundus and detrusor
when using the single-dose protocol, phenylephrine produced three
identical maximum contractions when stimulated with maximum and
EC50 concentrations, such that second (Trial 2) and third (Trial 3)
contractions, when normalized to the first (Trial 1) contraction, were
not different (control, Figure 7).
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Figure 7 PE single dose responses. Comparisons of maximum force values
(a) and half-maximum force values (b) produced by Trial 2 and Trial 3 singledose phenylephrine stimulus in fundus muscle strips. Tissues were either not
treated (control) or treated with an antagonist for 20 min before Trial 3. Data
are means+s.e.mean. Control, n=9; 10−6 M GF-109203X (GF), n=6; 10−5 M
HA-1077 (HA), n=4; 3×10−6 M Y-27632 (Y), n=4.

Unlike that seen with carbachol stimulation in fundus, but like
that seen with carbachol stimulation in detrusor, the PKCc,n inhibitor,
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GF-109203X, inhibited contractions produced by both a maximum
(Figure 7a) and EC50 (Figure 7b) concentration of phenylephrine in
fundus. Also, as seen with carbachol stimulation in both fundus and
detrusor, the ROK blockers HA-1077 and Y-27632, inhibited
contractions produced by both a maximum (Figure 7a) and EC50
(Figure 7b) concentration of phenylephrine in fundus.

Analysis of tachyphylaxis of carbachol-induced
contractions
A well-known phenomenon linked to receptor stimulation is
tachyphylaxis, a reduction in contractile responsiveness resulting from
the continued occupation of a particular receptor by an agonistic ligand
that is often linked to receptor (Benovic et al., 1988) or post-receptor
(Ratz, 1995) down-regulation. Because we used two distinct activation
protocols in this study that differed in the duration of receptor
stimulation, and we examined multiple stimulations, we could use
these data to compare the degree of tachyphylaxis caused by
exposure to carbachol in fundus and detrusor. Moreover, because
tissues were activated with carbachol, a receptor stimulus, as well as
KCl, an agent that bypasses receptors, we could obtain information
about tachyphylaxis potentially caused by post-receptor downregulation (Ratz, 1995; 1999; Ratz et al., 1995; 1996).
Detrusor displayed classical tachyphylaxis of response, in that
the maximum contraction produced by the maximum concentration of
carbachol during a carbachol CRC was significantly weaker than the
maximum concentration produced by an equivalent carbachol
concentration added as a single-dose stimulus (Figure 8a, detrusor).
Interestingly, fundus displayed the opposite response. The single-dose
maximum stimulus produced a weaker maximum contraction than did
the equivalent concentration of carbachol when employed using a CRC
(Figure 8a, fundus), implying that in fundus, exposure to carbachol
causes up-regulation rather than down-regulation of responsiveness.
This up-regulation may be due to a post-receptor phenomenon
because, in fundus, KCl produced a significantly greater contraction
after compared to before carbachol exposure, while KCl produced the
same degree of contraction before and after exposure to carbachol in
detrusor (Figure 8b).
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Figure 8 Comparison of the maximum force responses produced in fundus
and detrusor strips when contracted by (a) the maximum concentration of
carbachol using the two different protocols in this study, concentrationresponse curve (CRC) and single-dose stimulation, and (b) 109 mM KCl
before and after stimulation with three single-dose activations of 3×10−6 M
carbachol. In (a), the maximum force value was derived from the first CRC,
and the maximum force produced in response to the first single-dose
carbachol at 3×10−6 M was used. Data in (a) are average values+s.e.mean,
n=14 for fundus data from CRCs, n=8 for fundus single-dose stimulus, n=4
British Journal of Pharmacology, Vol. 137, No. 7 (December 2002): pg. 983-992. DOI. This article is © Wiley and
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.

20

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

from detrusor CRCs, n=7 from detrusor single-dose stimulus. Data in (b) are
average±s.e.mean. Fundus n=9, detrusor n=7.

Discussion
This study used selective kinase inhibitors to identify the degree
of participation of ROK- and PKC-induced Ca2+-sensitization in
muscarinic and -adrenoceptor stimulated contraction of isolated strips
of rabbit stomach fundus. The data support the hypothesis that both
ROK and PKC participated in fundus contraction. However, ROK
participated in muscarinic receptor-induced contraction and αadrenoceptor-induced contraction, while PKC participated only in αadrenoceptor-induced contraction. By comparison, muscarinic
receptor-induced contraction of bladder wall (detrusor) smooth muscle
involved ROK and PKC. This study also revealed that muscarinic
receptor stimulation caused up-regulation of fundus contraction that
appeared to be caused by post-receptor mechanisms.
It is now known that ROK and conventional and novel PKC
isoforms (PKCc,n) play prominent roles in regulation of smooth muscle
contraction (Somlyo & Somlyo, 2000; Eto et al., 2001; Pfitzer, 2001),
but the relative contribution that each makes in regulation of force in
the many diverse smooth muscle types is only now being revealed.
The gut represents a complex organ system comprised of multiple
types of smooth muscle. It is evident that ROK participates in
regulation of ileal smooth muscle contraction, but whether ROK plays a
role in regulation of vertebrate stomach smooth muscle remains to be
determined. Our data using the selective ROK inhibitors, Y-27632 and
HA-1077 (Uehata et al., 1997; Davies et al., 2000; Sward et al.,
2000), support the hypothesis that ROK participates in development of
maximum contraction of rabbit stomach fundus produced by both the
muscarinic receptor agonist, carbachol, and the -adrenoceptor
agonist, phenylephrine. These data provide in vitro support of the in
situ finding that Y-27632 reduces gastric motility in rat (Tomomasa et
al., 2000). Moreover, our data demonstrate that stimulation of
muscarinic receptors does not produce activation of identical
subcellular signalling systems in chicken gizzard and rabbit stomach
fundus smooth muscles, because Y-27632 had no effect on chicken
gizzard contraction (Anabuki et al., 2000), but produced significant
inhibition of rabbit fundus smooth muscle in the present study.
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Both ROK and PKCc,n may participate in regulation of smooth
muscle contraction by causing an increase in the Ca2+ sensitivity of
contraction through inhibition of myosin light chain phosphatase.
However, the targets of these enzymes are different in that ROK acts
by phosphorylating the large regulatory subunit of myosin
phosphatase (MYPT) and by directly phosphorylating serine-19 of the
20 kDa myosin light chains (Hartshorne et al., 1998; Woodsome et al.,
2001), whereas PKCc,n acts by phosphorylating and activating an
inhibitor of myosin phosphatase, CPl-17 (Eto et al., 2001; Woodsome
et al., 2001). Our data showed that -adrenoceptor stimulation
produced a weak contraction of rabbit stomach smooth muscle that
was inhibited by ROK inhibitors and by GF-109203X, an inhibitor of
PKCc,n (Gailly et al., 1997; Eto et al., 2001). Thus, although muscarinic
receptor stimulation of rabbit fundus smooth muscle does not appear
to cause contraction through activation of PKCc,n, -adrenoceptor
activation does. Moreover, we found that GF-109203X inhibited
detrusor smooth muscle contractions produced by muscarinic receptor
stimulation, indicating that the signal transduction events leading from
muscarinic receptor stimulation to contraction differ in detrusor and
fundus.
Tachyphylaxis is a general phenomenon describing downregulation of a cell signalling system, that when applied to smooth
muscle contraction, refers to reductions in contractile activity
(Furchgott, 1955). Stimulation of receptors can lead to tachyphylaxis,
which may reflect receptor down-regulation (Benovic et al., 1988) or
post-receptor down-regulation (Ratz, 1995). In the present study,
exposure of detrusor smooth muscle to multiple concentrations of
carbachol in a continuous fashion to establish a cumulative
concentration-response curve (CRC) led to tachyphylaxis. That is, a
maximum concentration of carbachol produced a stronger contraction
when tissues were exposed only briefly to that single concentration
than when tissues were subjected to a cumulative CRC. Surprisingly,
fundus produced the opposite response; brief stimulation with a single
concentration produced a weaker response than that produced by a
cumulative CRC. The finding that KCl-induced contractions were
greater in fundus smooth muscle after, as compared to before, the
tissue had been exposed to carbachol suggests that carbachol induced
up-regulation of post-receptor signalling systems leading to
contraction. These data together support the notion that the
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fundamental signalling system linking muscarinic receptor stimulation
with contraction of fundus and detrusor is different. The implication of
these results is that these differences may be utilized to design
therapeutic treatments of disorders involving gastrointestinal smooth
muscle that may be free of adverse effects related to actions on other
smooth muscle systems.
Precisely how prolonged or repeated stimulation of muscarinic
receptors lead to up-regulation of fundus was not identified in the
present study. However, it is tempting to speculate that either Ca2+
signalling or Ca2+ sensitivity were involved. For example, the
sacoplasmic reticulum of smooth muscle regulates the degree of Ca2+
that can be made available to the cytosol (Lee et al., 2002), and upregulation of force produced by fundus may have been due to
enhanced loading of sarcoplasmic reticular Ca2+ stores. Up-regulation
of force may also have been due to enhanced activity of an enzyme
activated by muscarinic receptors that is responsible for Ca2+
mobilization, such as phospholipase C (Schmidt et al., 1998). An
alternative hypothesis is that up-regulation was due to enhancement
in the sensitivity of contractile proteins to Ca2+. Several enzymes in
addition to ROK and PKC, including ILK (Deng et al., 2001), ZIP-like
kinase (MacDonald et al., 2001; Niiro & Ikebe, 2001), MAPKAP kinase2 (Komatsu & Hosoya, 1996), and PAK (van eyk et al., 1998), have
recently been identified that directly or indirectly elevate the degree of
myosin light chain phosphorylation independently of an increase in
[Ca2+]i. However, whether any of these enzymes were involved in upregulation of fundus remains to be determined. Moreover, because it
has been proposed that ZIP-like kinase and possibly other kinases may
be required downstream from ROK in order for ROK to regulate
smooth muscle force (MacDonald et al., 2001), the present study
cannot rule out the participation of additional kinases in regulation of
fundus contraction.
In conclusion, these data suggest that ROK plays a critical role
in the regulation of carbachol- and phenylephrine-induced contractions
in rabbit fundus smooth muscle, and that PKC participates in
phenylephrine- but not carbachol-induced contraction. These results
are in contrast to that seen in chicken gizzard smooth muscle, in which
ROK is reported to exist but not to play a role in muscarinic receptorinduced contraction. By contrast, both ROK and PKC appear to
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participate in regulation of carbachol-induced contraction of rabbit
detrusor. Moreover, carbachol appeared to produce a long-lasting upregulation of contraction of fundus, but not detrusor, that may have
involved post-receptor signalling events.
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